Bioxytran, Inc. (BIXT)

Bioxytran Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.01	0.03	0.3	0.07	0.04
Cash & Short-Term Investments	0.01	0.01	0.03	0.3	0.07	0.04
Cash Growth	-58.18%	-80.24%	-91.17%	308.25%	73.57%	-75.42%
Prepaid Expenses	-	-	-	-	-	0.27
Total Current Assets	0.01	0.01	0.03	0.3	0.07	0.32
Other Intangible Assets	-	-	-	-	-	0.01
Long-Term Deferred Charges	0.14	0.13	0.11	0.08	0.05	-
Total Assets	0.16	0.14	0.14	0.37	0.12	0.33
Accounts Payable	0.29	0.15	0	0	-	0
Accrued Expenses	0.86	0.28	0.3	1.46	1.16	0.35
Short-Term Debt	1.4	1.09	1.93	2.17	2.12	1.61
Other Current Liabilities	0.52	0.41	1.01	0.04	-	0.31
Total Current Liabilities	3.06	1.93	3.24	3.66	3.28	2.27
Total Liabilities	3.06	1.93	3.24	3.66	3.28	2.27
Common Stock	0.09	0.09	0.14	0.12	0.11	0.1
Additional Paid-In Capital	17.47	17	13.09	8.39	5.88	1.8
Retained Earnings	-20.52	-18.92	-15.7	-11.22	-8.75	-4.72
Comprehensive Income & Other	0.01	-	0.05	-	-	-
Total Common Equity	-2.95	-1.84	-2.42	-2.7	-2.76	-2.83
Minority Interest	-	-	-0.68	-0.59	-0.4	0.89
Shareholders' Equity	-2.9	-1.79	-3.1	-3.29	-3.16	-1.94
Total Liabilities & Equity	0.16	0.14	0.14	0.37	0.12	0.33
Total Debt	1.4	1.09	1.93	2.17	2.12	1.61
Net Cash (Debt)	-1.38	-1.09	-1.9	-1.87	-2.05	-1.57
Net Cash Per Share	-0.02	-0.01	-0.01	-0.02	-0.02	-0.02
Filing Date Shares Outstanding	99.1	88.88	166.49	123.5	110.84	100.75
Total Common Shares Outstanding	88.99	86.78	145.64	123.25	110.84	97.45
Working Capital	-3.05	-1.93	-3.22	-3.37	-3.21	-1.95
Book Value Per Share	-0.03	-0.02	-0.02	-0.02	-0.02	-0.03
Tangible Book Value	-2.95	-1.84	-2.42	-2.7	-2.76	-2.84
Tangible Book Value Per Share	-0.03	-0.02	-0.02	-0.02	-0.02	-0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.